The medical device industry is no stranger to change, but the COVID-19 … [Read More...] about Vital Signs of the Medical Device Industry
Main Content
Today on MassDevice
- Once-a-week insulin dosing shows promise in studies
- Abbott’s MitraClip doesn’t hinder oxygen levels, study shows
- AdvaMed launches medtech podcast
- Oncocyte acquires Chronix Biomedical
- FDA nixes EUA for Lilly’s bamlanivimab
- Seigla Medical gains CE mark for guide catheter extension
- Contego Medical carotid stent wins CE mark approval
White Papers

How to Succeed with a Hybrid Approach to Clinical Monitoring
By Elise Ondak
At the start of this year, IMARC Research conducted a survey of over 100 … [Read More...] about How to Succeed with a Hybrid Approach to Clinical Monitoring
Sponsored Content

Dreams of a Common Engineering Database During Product Development
By Chuck Smith, Principal Engineer at Sunrise Labs In working with geographically distributed teams, integration of the team members is critical to communicate effectively and to avoid … [Read More...] about Dreams of a Common Engineering Database During Product Development

Precision centerless grinding: Innovative approach to a traditional manufacturing process
Resonetics’ centerless grinding process enables a nearly limitless level of micro-scale geometries for mandrels, guide wires, core wires and catheter components. With expert process knowledge, machine … [Read More...] about Precision centerless grinding: Innovative approach to a traditional manufacturing process
Legal News
Heater-Cooler suit against LivaNova revived
A Louisiana resident whose lawsuit against LivaNova (NSDQ:LIVN) was thrown out will have another … [Read More...] about Heater-Cooler suit against LivaNova revived
Medtronic can’t shake suit over FDA clearance of spinal devices
A federal appeals court has ruled that Medtronic must face a whistleblower lawsuit over FDA … [Read More...] about Medtronic can’t shake suit over FDA clearance of spinal devices
Illumina postpones $8B Grail deal amid FTC challenge
Illumina (NSDQ:ILMN) has delayed its proposed $8 billion acquisition of Grail amid a FTC … [Read More...] about Illumina postpones $8B Grail deal amid FTC challenge
Merit Medical must face shareholder lawsuit
A federal judge in California quashed a bid by Merit Medical to dismiss a lawsuit alleging … [Read More...] about Merit Medical must face shareholder lawsuit
Abbott’s St. Jude Medical wins patent spat over catheterization method
St. Jude Medical, now part of Abbott, has won a patent dispute over a method for using a double … [Read More...] about Abbott’s St. Jude Medical wins patent spat over catheterization method
Second Sight’s merger with Pixium Vision may fall through
Second Sight's plans to raise $27.9 million from a private placement appear to have generated … [Read More...] about Second Sight’s merger with Pixium Vision may fall through
Federal judge won’t let Boston Scientific avoid Watchman lawsuit
A federal judge in western North Carolina has declined to dismiss a wrongful death lawsuit against … [Read More...] about Federal judge won’t let Boston Scientific avoid Watchman lawsuit
In case you missed it
- Boston Scientific settles host of state pelvic mesh lawsuits for nearly $189M
- Investors sue Decision Diagnostics over COVID-19 test
- Allergan must face breast implant class action
- Feds charge medical testing company with fraud
- Theranos founder Elizabeth Holmes’s trial delayed again — this time over pregnancy
Mergers & Acquisitions.

Oncocyte acquires Chronix Biomedical
Oncocyte (NSDQ:OCX) announced today that it completed its acquisition of molecular diagnostics company Chronix Biomedical. Irvine, Calif.-based Oncocyte’s acquisition includes the intellectual property and technology for Chronix’s TheraSure copy number instability (CNI) monitor test for immune therapy monitoring, according to a news release. Oncocyte also gains organ transplant technology and the associated patent portfolio developed […]

MedTech 100 roundup: Industry skies to all-time high
The medtech industry hit a slight lull in the early stages of 2021 and, after signs of a rebound, it has soared beyond levels ever before seen. MassDevice‘s MedTech 100 Index had been building up steam in the month of April, rising from 102.16 points at the beginning of March all the way to 109.39 to […]

Amgen completes $1.9B acquisition of Five Prime Therapeutics
Amgen (NSDQ:AMGN) announced today that it completed its $1.9 billion acquisition of Five Prime Therapeutics (NSDQ:FPRX). Thousand Oaks, Calif.-based Amgen has officially acquired South San Francisco-based Five Prime for $38 per share in cash, reaching an equity value of approximately $1.9 billion. The acquisition was initially announced on March 4, 2021. Get the full story at our sister […]

SeaSpine prices $87.8M offering
SeaSpine (NSDQ:SPNE) announced that it priced an underwritten public offering worth proceeds of approximately $87.8 million. Carlsbad, Calif.-based SeaSpine is offering 4.5 million shares of its common stock at a public offering price of $19.50 per share, leading to the $87.8 million expected in proceeds before deducting discounts, commissions and other expenses, according to a […]

Vicarious Surgical to go public in $1.1B SPAC deal
Vicarious Surgical will go public through a $1.1 billion special purpose acquisition company (SPAC) deal, the robotic surgery pioneer announced today. Vicarious, which has sought to bring robotics and virtual reality to minimally invasive surgery, will trade on the New York Stock Exchange under the symbol RBOT after the merger with D8 Holdings. Hong Kong–based […]

Siemens Healthineers completes Varian acquisition
Siemens Healthineers (ETR:SHL) announced today that it completed its acquisition of Varian Medical Systems (NYSE:VAR). In August, the companies announced that Siemens would acquire Varian in a $16.4 billion deal to create what the companies said will be the most comprehensive cancer care portfolio in the industry. Varian shareholders approved the deal in October. Several personnel moves have […]

Thermo Fisher to buy PPD for $17B
Thermo Fisher Scientific (NYSE:TMO) announced today that it agreed to acquire PPD (NSDQ:PPD) for $17.4 billion. The boards of directors for both companies approved the definitive agreement, which will see Thermo Fisher buy PPD for $47.50 per share, totaling $17.4 billion, plus the assumption of approximately $3.5 billion of net debt, according to a news […]